Brezofil

Brezofil100 mg/5 ml

Doxophylline

Incepta Pharmaceuticals Ltd.

Product Code : 2455
MRP 100.00
10% Off
Best PriceTk
/
1
Section

Alternatives

See All
Product Image
10% Off

Doxolator100 mg/5 m

Doxophylline

Ziska Pharmaceuticals Ltd.

90.00
100.00
Add to cart
Product Image
10% Off

Doxorin100 mg/5 m

Doxophylline

Opsonin Pharma Ltd.

90.00
100.00
Add to cart
Product Image
10% Off

Ascova100 mg/5 m

Doxophylline

Labaid Pharma Ltd.

90.00
100.00
Add to cart
Product Image
10% Off

Doximar100 mg/5 m

Doxophylline

ACI Limited

90.00
100.00
Add to cart
Product Image
10% Off

Doxofyl100 mg/5 m

Doxophylline

Popular Pharmaceuticals Ltd.

90.00
100.00
Add to cart
Product Image
10% Off

Doxoma100 mg/5 m

Doxophylline

Drug International Ltd.

72.00
80.00
Add to cart
Product Image
10% Off

Fixolin100 mg/5 m

Doxophylline

Beximco Pharmaceuticals Ltd.

90.00
100.00
Out Of Stock
Product Image
10% Off

Unifylin100 mg/5 m

Doxophylline

General Pharmaceuticals Ltd.

90.00
100.00
Add to cart
Section

Medicine overview

Indications of Brezofil 100 mg/5 ml

Brezofil 100 mg/5 ml is used to treat in following indications:  Bronchial asthma, Bronchospasm, Chronic obstructive pulmonary disease (COPD), Pulmonary disease with spastic bronchial component.

Theropeutic Class

Bronchodilator, Methyl xanthine derivatives

Pharmacology

Brezofil 100 mg/5 ml is a novel bronchodilator. It structurally differs from Theophylline due to the presence of a dioxolane group in position 7. Brezofil 100 mg/5 ml selectively inhibits phosphodiesterase 4 thereby relaxes bronchial smooth muscle. However, differently from Theophylline, Brezofil 100 mg/5 ml appears to have decreased affinities toward adenosine A1 and A2 receptors, which may account for the better safety profile of the drug. Brezofil 100 mg/5 ml is reported to inhibit platelet activating factor (PAF) and generation of leukotriene production.

Dosage & Administration of Brezofil 100 mg/5 ml

Elderly: 200 mg tablet two or three times daily.Adults: 400 mg tablet two or three times daily or as prescribed by the physician. Children: >12 years of age: 10 ml syrup or 200 mg tablet two or three times daily. 6-12 years of age: 6-9 mg/kg body weight two times daily, i.e. if body weight is 10 kg, 3 ml (60 mg) two times daily or as prescribed by the physician. If required daily dose of Brezofil 100 mg/5 ml is 400 mg then Brezofil 100 mg/5 ml SR tablet to be taken once daily or as prescribed by the physician

Dosage of Brezofil 100 mg/5 ml

Elderly: 200 mg tablet two or three times daily.Adults: 400 mg tablet two or three times daily or as prescribed by the physician. Children: >12 years of age: 10 ml syrup or 200 mg tablet two or three times daily. 6-12 years of age: 6-9 mg/kg body weight two times daily, i.e. if body weight is 10 kg, 3 ml (60 mg) two times daily or as prescribed by the physician. If required daily dose of Brezofil 100 mg/5 ml is 400 mg then Brezofil 100 mg/5 ml SR tablet to be taken once daily or as prescribed by the physician

Interaction of Brezofil 100 mg/5 ml

Brezofil 100 mg/5 ml should not be administered together with other xanthine derivatives. Toxic synergism with ephedrine has been documented for xanthines. Like other xanthines, concomitant therapy with troleandomycin, lincomycin, clindamycin, allopurinol, cimetidine, ranitidine, propranolol and anti-flu vaccine may decrease the hepatic clearance of xanthines causing an increase in blood levels. No evidence of a relationship between Brezofil 100 mg/5 ml serum concentrations and toxic events have been reported.

Contraindications

Brezofil 100 mg/5 ml is contraindicated in acute myocardial infarction. It is also contraindicated in patients with hypotension, in lactating women & patients who have shown hypersensitivity to its components.

Side Effects of Brezofil 100 mg/5 ml

Brezofil 100 mg/5 ml rarely causes serious side effects, however possible side effects are similar for taking excess amount of caffeine. These include: nausea, vomiting, headache, upset stomach and heartburn.

Pregnancy & Lactation

Animal reproduction studies indicate that, Brezofil 100 mg/5 ml does not cause fetal harm when administered to pregnant animals or can not affect reproduction capacity. However, since there is limited experience in human during pregnancy, xanthines should be given to pregnant women only if clearly needed. Brezofil 100 mg/5 ml is contraindicated in nursing mothers.

Precautions & Warnings

The half-life of xanthine derivatives is influenced by a number of known variables. It may be prolonged in patients with liver disease, in patients with congestive heart failure and in those patients taking certain other drugs like erythromycin, troleandomycin, lincomycin, allopurinol, cimetidine, propanolol and anti-flu vaccine. In these cases, a lower dose of Brezofil 100 mg/5 ml may be needed. Phenytoin, other anticonvulsants and smoking may cause an increase in clearance with a shorter mean half-life. In these cases higher doses of Brezofil 100 mg/5 ml may be needed.

Overdose Effects of Brezofil 100 mg/5 ml

In case of overdose severe cardiac arrhythmias and tonic-clonic seizure may occur. These effects may represent the first signs of intoxication. The appearance of side effects may require discontinuation of the treatment which, if necessary, at the physician’s discretion, may be resumed at lower doses after all signs and symptoms of toxicity have subsided.As there is no specific antidote, in case of overdose a symptomatic treatment of cardiovascular collapse should be instituted.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children. Brezofil 100 mg/5 ml should be used only on prescription of specialist physician.

Drug Classes

Bronchodilator, Methyl xanthine derivatives

Mode Of Action

Brezofil 100 mg/5 ml is a novel bronchodilator. It structurally differs from Theophylline due to the presence of a dioxolane group in position 7. Brezofil 100 mg/5 ml selectively inhibits phosphodiesterase 4 thereby relaxes bronchial smooth muscle. However, differently from Theophylline, Brezofil 100 mg/5 ml appears to have decreased affinities toward adenosine A1 and A2 receptors, which may account for the better safety profile of the drug. Brezofil 100 mg/5 ml is reported to inhibit platelet activating factor (PAF) and generation of leukotriene production.

Pregnancy

Animal reproduction studies indicate that, Brezofil 100 mg/5 ml does not cause fetal harm when administered to pregnant animals or can not affect reproduction capacity. However, since there is limited experience in human during pregnancy, xanthines should be given to pregnant women only if clearly needed. Brezofil 100 mg/5 ml is contraindicated in nursing mothers.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.